here are 4 mass. biotechs making noise at the ash conference so far
.
.in a news release, the drug's manufacturer, amgen, said the list price will be 5 a month or ,900 annually. costs to patients may vary depending on insurance.
.
http://lm360.us/Chu-father-of-Coppage-from-Raddon-et-chapendu?Lubkeneig=118
why novartis� landmark cancer drug approval is great news for bluebird
.
.
.
.
. my profile
.
.
in a news release, the drug's manufacturer, amgen, said the list price will be 5 a month or ,900 annually. costs to patients may vary depending on insurance. . http://lm360.us/Chu-father-of-Coppage-from-Raddon-et-chapendu?Lubkeneig=118
why novartis� landmark cancer drug approval is great news for bluebird
.
.
.
.
. my profile
.
.
-
.
.
. my profile
.
.